Mutan (Fluoxetine)

Fluoxetine, the active ingredient in Mutan, is a selective serotonin reuptake inhibitor (SSRI) presented as an oral dosage form for oral use. It is prescribed for several psychiatric conditions, including major depressive disorder, obsessive‑compulsive disorder, panic disorder, bulimia nervosa, and premenstrual dysphoric disorder, primarily in adult patients.

GNH USA supplies Mutan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution to meet clinical demand.

Fluoxetine is an SSRI that modulates serotonergic pathways in several psychiatric disorders, providing therapeutic benefit across multiple conditions.

- Major depressive disorder: alleviates depressive symptoms, improves mood and functional capacity. - Obsessive‑compulsive disorder: reduces intrusive thoughts and compulsive behaviors, enhancing daily functioning. - Panic disorder: decreases frequency and intensity of panic attacks, supporting anxiety control. - Bulimia nervosa: diminishes binge‑eating episodes and associated purging behaviors. - Premenstrual dysphoric disorder: eases mood swings, irritability and physical symptoms linked to the menstrual cycle.

Fluoxetine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea - Headache - Insomnia - Dry mouth

Serious or Rare Side Effects: - Serotonin syndrome - Suicidal thoughts or behavior - Severe allergic reaction (anaphylaxis)

When prescribing fluoxetine, clinicians should observe several precautionary measures to ensure patient safety.

- Assess psychiatric history: monitor for worsening depression or emergence of suicidal ideation. - Avoid abrupt discontinuation: taper dose under medical supervision to reduce discontinuation syndrome. - Caution in hepatic impairment: consider dose adjustment or increased monitoring. - Use with caution alongside anticoagulants: increased risk of bleeding may occur. - Store at ambient temperature below 25°C: keep in original packaging, protect from moisture.

Fluoxetine interacts with several medications; understanding the interaction level guides safe co‑administration.

Major Interactions (Avoid): - MAO inhibitors: concurrent use can precipitate serotonin syndrome, a potentially life‑threatening condition. - Thioridazine: combined therapy may cause marked QT interval prolongation and cardiac arrhythmias. - Pimozide: risk of severe cardiac effects, including torsades de pointes, when used together.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of gastrointestinal bleeding when taken with fluoxetine. - Warfarin: fluoxetine can enhance anticoagulant effect, requiring closer INR monitoring. - Other serotonergic agents (e.g., tramadol, triptans): potential for additive serotonin toxicity.